Live Breaking News & Updates on Immunology Hospital Overall

Stay updated with breaking news from Immunology hospital overall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Benralizumab noninferior to mepolizumab for eosinophilic granulomatosis with polyangiitis

1. In this randomized controlled trial, benralizumab was noninferior for beginning remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) compared to mepolizumab. 2. Adverse events occurred in 90% and 96% of patients in the benralizumab and mepolizumab groups, respectively. Evidence Rating Level: 1 (Excellent) Study Rundown: EGPA is an inflammatory disorder with patients experiencing ....

Minute Medicine Inc , Rating Level , Chronic Disease , Eosinophilic Granulomatosis With Polyangiitis ,

Spring allergies bloom in the valley, locals advised on prevention methods

Spring is here. But for many of us that means sneezing, a runny nose and itchy eyes."What you wanna do in the evening before you go to bed, very important to wa ....

United States , Belmont County , Neal Dunn , Health Medical Pharma , Respiratory Diseases , Chronic Obstructive Pulmonary Disease , Immune System , Chronic Lower Respiratory Diseases ,